Evidence map›Paper›PMID 35363600›Full record

Trial reportAnnals of the American Thoracic Society2022

Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.

Trisha M Parekh, Erika S Helgeson, John Connett, Helen Voelker, Sharon X Ling, Stephen C Lazarus, Surya P Bhatt, David M MacDonald, Takudzwa Mkorombindo, Ken M Kunisaki and 3 more

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Annals of the American Thoracic Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Appraisal of β-Blocker Use in Patients with Cardiovascular Disease and Chronic Obstructive Pulmonary Disease.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Trisha M ParekhUniversity of Alabama at Birmingham, Birmingham, Alabama.
Erika S HelgesonUniversity of Minnesota Academic Health Center, Minneapolis, Minnesota.
John ConnettUniversity of Minnesota, Minneapolis, Minnesota.
Helen VoelkerUniversity of Minnesota, Minneapolis, Minnesota.
Sharon X LingUniversity of Minnesota, Minneapolis, Minnesota.
Stephen C LazarusUniversity of California, San Francisco, San Francisco, California.
Surya P BhattUniversity of Alabama at Birmingham, Birmingham, Alabama.
David M MacDonaldUniversity of Minnesota, Minneapolis, Minnesota.
Takudzwa MkorombindoUniversity of Alabama at Birmingham, Birmingham, Alabama.
Ken M KunisakiUniversity of Minnesota, Minneapolis, Minnesota.ORCID 0000-0001-8644-2827
Spyridon FortisUniversity of Iowa Hospitals and Clinics, Iowa City, Iowa; and.ORCID 0000-0001-7807-6740
David KaminskyUniversity of Vermont College of Medicine, Burlington, Vermont.
Mark T DransfieldUniversity of Alabama at Birmingham, Birmingham, Alabama.
University of Minnesota · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of Iowa Hospitals and Clinics · USUniversity of Vermont · US

Funding

Development of a Community Health Worker-Led Stress Reduction Intervention for Low-Income COPD PatientsK23HL153672 · NHLBI · UNIVERSITY OF TEXAS AT AUSTIN · PI PAREKH, TRISHA M · 2020 to 2024
$840k
UAB Mentoring Program in COPD Patient Oriented ResearchK24HL140108 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DRANSFIELD, MARK T · 2018 to 2022
$439k
NHLBI NIH HHS K23 HL153672NHLBI NIH HHS K24 HL140108
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bronchodilator AgentsPulmonary Disease, Chronic ObstructiveForced Expiratory VolumeHumansLungMetoprololVital CapacityBronchodilator AgentsMetoprololbronchodilator responseCOPDexacerbationsspirometryβ-blockers

Identifiers

PMID35363600
PMCPMC9528740
OpenAlexW4220807010

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.